Clinical Trials Browser

Suspended × INDUSTRY × Fibrolamellar hepatocellular carcinoma × Clear all

NCT05603572 2025-06-05

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Phase 1/2 Suspended

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular